Today: 9 June 2026
Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
24 January 2026
2 mins read

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

New York, Jan 24, 2026, 10:18 (EST) — The market has closed.

Exxon Mobil shares ended Friday roughly 1% higher at $134.97. Late in the session, the company confirmed that its XTO unit has opened a virtual data room to gauge buyer interest in select Eagle Ford shale assets in South Texas. Sources say the sale process is being handled internally, without investment banks. The package covers about 168,000 net acres and more than a thousand wells, with a potential value topping $1 billion. Exxon said this aligns with its ongoing strategy to “continually evaluate and optimize” its portfolio, focusing on growth in the Permian Basin, Guyana, and liquefied natural gas (LNG). Reuters

The marketing push comes at a tricky time for energy investors. Oil prices have been volatile, reacting sharply to policy updates and supply hiccups. Traders are quick to hit anything suggesting rising costs or weaker returns.

As U.S. markets remain closed for the weekend, all eyes shift to Monday’s open and a packed schedule for crude and energy stocks. The key issue: is Exxon trimming its holdings cautiously, or is this a hint at bigger shifts in its U.S. shale strategy?

A “data room” is a secure online vault containing well files, production data, and contracts that bidders sift through before submitting offers. “Non-operated” interests refer to stakes where Exxon holds a share, but another company manages the wells.

Oil prices gave energy stocks a lift late Friday. Brent ended the day at $65.88 a barrel, up 2.8%, while U.S. West Texas Intermediate (WTI) climbed 2.9% to $61.07. The gains came as Washington ramped up pressure on Iran and Kazakhstan’s Tengiz oil supply remained offline; Chevron confirmed output there hadn’t resumed following a fire. This rebound reversed a roughly 2% drop from the previous day, when tariff and military threat talk cooled off.

Weather risk is factoring in. A winter storm named Fern has already caused crude and gas shut-ins across major U.S. basins. Energy Aspects analysts put total crude losses near 300,000 barrels per day. Distillate markets have tightened as cold weather drives up demand. “There is the potential for a surge in distillate demand,” said veteran oil analyst Tom Kloza. Reuters

Supply discipline is still in play. Baker Hughes reported the U.S. oil and gas rig count ticked up by one this week, reaching 544. That’s down 32 rigs compared to a year ago, showing producers aren’t scrambling to ramp up despite crude’s recent price jumps.

Yet the weekend story could shift quickly. Should the Eagle Ford sale attract limited interest or bids below the rumored $1 billion-plus price tag, the “portfolio cleanup” story would lose steam, leaving oil prices to do the heavy lifting for the stock.

At the start of the week, XOM is set to move in line with crude, as investors await more details on the timing and terms of the Eagle Ford package. Near-term market action will hinge on winter outages, concerns over Iran’s supply, and the restart of Kazakhstan’s Tengiz field.

Exxon plans to release its fourth-quarter 2025 earnings around 5:30 a.m. CT on Friday, Jan. 30. The results will be posted on its website and filed in an 8-K.

Stock Market Today

  • TSX Penny Stocks Spotlight: Imagine Lithium, Kenorland Minerals, Torrent Capital Analysis
    June 9, 2026, 9:59 AM EDT. Imagine Lithium Inc., a debt-free junior mineral explorer with a market cap of CA$5.11 million, remains unprofitable but shows reduced losses. Kenorland Minerals Ltd., valued at CA$164.09 million, faces declining revenues and a net loss of CA$5.14 million in Q1 2026; its cash runway is under one year amid ongoing exploration. Torrent Capital Ltd., an investment firm with CA$19.47 million market cap, invests in public, private equities, and cryptocurrencies. Despite volatile markets, these TSX penny stocks reflect growth potential but carry risks due to earnings variability and economic uncertainties. Investors should weigh financial health ratings and operational progress carefully before committing.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings
Previous Story

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings

ASML stock price: What to watch before Jan. 28 earnings after Intel jolts chip mood
Next Story

ASML stock price: What to watch before Jan. 28 earnings after Intel jolts chip mood

Go toTop